Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study

JAMA. 1999 Feb 3;281(5):415; author reply 417-9.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use*
  • Anticholesteremic Agents / therapeutic use*
  • Coronary Disease / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Lovastatin / therapeutic use*
  • Simvastatin / therapeutic use*

Substances

  • Anti-Arrhythmia Agents
  • Anticholesteremic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lovastatin
  • Simvastatin